Osmolex ER™ (amantadine) – New drug approval
February 19, 2018 - Osmotica Pharmaceutical announced the FDA approval of Osmolex ER (amantadine), for the treatment of Parkinson's disease and for the treatment of drug-induced extrapyramidal reactions in adult patients.
Download PDF
